Pharmaceuticals news FT.com

Novo Nordisk cuts sales forecasts on lower US demand for obesity drug

First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up

May 7, 2025 - 07:25
 0
Novo Nordisk cuts sales forecasts on lower US demand for obesity drug
First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up
Read More

Tags:

Previous Article

My Week In Cars: New Steve Cropley/Matt Prior podcast (ep.139)

Next Article

Trade associations urge Brussels to back Europe’s Rail successor

Related Posts

Europe’s last maker of key antibiotics ingredients shuts biggest domestic factory

Europe’s last maker of key antibiotics ingredients shut...

May 6, 2025  0

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Swiss drugmaker Novartis to invest $23bn in US manufact...

Apr 26, 2025  0

NHS signs deal with Scancell in ambitious skin cancer trial

NHS signs deal with Scancell in ambitious skin cancer t...

Apr 26, 2025  0